Paragon Bioservices Revenue and Competitors

Claim your profile

Location

$20M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Paragon Bioservices's estimated annual revenue is currently $13.6M per year.(i)
  • Paragon Bioservices received $5.0M in venture funding in August 2018.
  • Paragon Bioservices's estimated revenue per employee is $189,444
  • Paragon Bioservices's total funding is $20M.

Employee Data

  • Paragon Bioservices has 72 Employees.(i)
  • Paragon Bioservices grew their employee count by -16% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3M32-14%$17.5MN/A
#2
$3.9M41-15%$10.5MN/A
#3
$18.8M992%$69.4MN/A
#4
$12.6M61-6%N/AN/A
#5
$2.6M343%N/AN/A
#6
$1.6M1731%$40MN/A
#7
N/A1525%N/AN/A
#8
$6.8M44N/AN/AN/A
#9
$2.2M3011%N/AN/A
#10
$1.6M1025%N/AN/A
Add Company

Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon's aim is to build strong client partnerships with the world's best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic protein, and other complex biologics.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$20M

Total Funding

72

Number of Employees

$13.6M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Paragon Bioservices News

2022-04-17 - Bioservices Market Size 2022 : COVID-19 Impact on Industry ...

The growth of the Bioservices market was mainly driven by the ... Inc, Ology Bioservices, Inc., Paragon Gene Therapy, Park Bioservices,...

2022-04-06 - Catalent injecting $160m into UK failed vaccine plant ...

... Maryland (added through the 2019 acquisition of Paragon Bioservices), ploughed $100 million into its Anagni, Italy fill-finish facility...

2022-04-06 - Stem Cell Services Market Key Trends And Opportunity Areas ...

Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cell, Crioestaminal, LifeCell, ViaCord, Pepro Tech, Health Baby. Photo of Carl Allison Carl...

2019-09-08 - Catalent's legacy business outshined by acquisitions

By April of 2019, Catalent had agreed to a $1.2 billion acquisition of gene therapy developer Paragon Bioservices. And most recently, the ...

2019-09-07 - Viral vector and plasmid market set for rapid growth

Just this year, Catalent bought out California-based Paragon Bioservices? and Thermo Fisher Scientific acquired Brammer Bio?, located in ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.4M72-3%N/A
#2
$11M73109%N/A
#3
$32.5M736%N/A
#4
$12M73-3%N/A
#5
$15.8M73-9%N/A

Paragon Bioservices Funding

DateAmountRoundLead InvestorsReference
2014-10-29$13.0MUndisclosedNewSpring CapitalArticle
2015-08-21$2.0MUndisclosedArticle
2018-08-14$5.0MUndisclosedArticle